Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01821300 · ClinicalTrials.gov registry record
Down Syndrome Metabolic Health Study
A clinical trial of Down Syndrome and Trisomy 21, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- 257
- Enrollment target
- 2
- Study locations
NCT01821300 is a study of Down Syndrome and Trisomy 21 that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 257 participants, below the 2,467-participant average among 54 other Down Syndrome trials with a reported enrollment target (90% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT01821300, a study of Down Syndrome and Trisomy 21, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- 257 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this research study is to determine which measures best capture cardiovascular disease (CVD) risk and type 2 diabetes (T2DM) risk in children and adolescents with Down syndrome (DS). We hypothesize that DS is associated with worse cardiometabolic risk factors for a given body mass index compared to controls. This difference arises at least in part, from increased fat tissue.
Conditions Studied
Study Locations (2)
District of Columbia
- Children's National Medical Center - Washington D.C.
Pennsylvania
- The Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 257 participants |
| Start Date | 2013-02 |
| Est. Completion | 2017-08-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01821300
The ClinicalTrials.gov registry entry for NCT01821300 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 257 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,467-participant average among 54 other Down Syndrome trials with a reported enrollment target (90% lower). The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Down Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT01821300 reports 2 study locations spanning 2 distinct geographic areas - top geographies include District of Columbia, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01821300 about?
NCT01821300 is a clinical study titled "Down Syndrome Metabolic Health Study". The purpose of this research study is to determine which measures best capture cardiovascular disease (CVD) risk and type 2 diabetes (T2DM) risk in children and adolescents with Down syndrome (DS). We hypothesize that DS is associated with worse cardiometabolic risk factors for a given body mass in...
What is the current status of trial NCT01821300?
This trial is currently completed. The enrollment target is 257 participants. The study started on 2013-02. Estimated completion is 2017-08-25.
What conditions does trial NCT01821300 study?
This clinical trial studies the following conditions: Down Syndrome, Trisomy 21.
Who is sponsoring clinical trial NCT01821300?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01821300 being conducted?
This trial has 2 study locations across District of Columbia, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Down Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
RECRUITING · NA
-
Brain Outcomes With Lifestyle Change in Down Syndrome
RECRUITING · NA
-
Trial-Ready Cohort-Down Syndrome (TRC-DS)
RECRUITING
-
The Human Trisome Project
RECRUITING
-
Evaluating Treatment of ADHD in Children with Down Syndrome
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.